Clinical trial
A Double-blind, Randomized, Placebo-controlled Study to Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.
NCT04833946 is registered in ClinicalTrials.gov with Vedic Lifesciences Pvt. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Double-blind, Randomized, Placebo-controlled Study to Assess the Effect of 336 Days Exposure of Paractin® on Pain & Disease Progression in Patients Suffering From Osteoarthritis of Knee Joint.
- Lead sponsor
- Vedic Lifesciences Pvt. Ltd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 13, 2021
- Completion date
- February 20, 2024
- Enrollment
- 80 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
knee osteoarthritis (knee oa)